Oral Presentation 5
Category: Tuberculosis (TB)- Drug-Resistant TB
Date: Saturday, Apr 27, 2024 | Time: 13:30-14:40 (GMT+8)
Moderator: Prof. Chen-Yuan Chiang (Taiwan) | Dr. Wen-Ta Yang (Taiwan)
Presentation Serial Number | Title | Presenter |
---|---|---|
OP-05-01 | HIGH-DOSE LINEZOLID: ADVERSE EVENTS AND OUTCOMES DURING BPAL
IMPLEMENTATION FOR PRE-EXTENSIVELY DRUG RESISTANT TB OR FAILED/INTOLERANT RIFAMPICIN RESISTANT TB PATIENTS IN VIETNAM |
Mrs. Thi-Mai-Phuong Nguyen |
OP-05-02 | ELEVATED PRETOMANID MINIMUM INHIBITORY CONCENTRATION AND TREATMENT OUTCOME OF TUBERCULOSIS PATIENTS | Dr. Jeya Deepa Bharathi |
OP-05-03 | SAFETY OF SHORTER ORAL MODIFIED BPAL REGIMEN IN MANAGEMENT OF PRE-EXTENSIVELY DRUG RESISTANT TUBERCULOSIS – INTERIM ANALYSIS | Dr. Balaji Ramraj |
OP-05-04 | IMPLEMENTING SHORTER-TREATMENT REGIMENS FOR DRUG-RESISTANT TUBERCULOSIS UNDER OPERATIONAL STUDY CONDITIONS IN TAJIKISTAN: PRELIMINARY RESULTS ON TREATMENT OUTCOMES | Dr. Zumrad Maxumova |
OP-05-05 | DOES SAME DURATION OF TREATMENT FOR PREXDR TB PATIENTS MANAGED WITH SHORTER ORAL BEDAQUILINE CONTAINING REGIMENS SUFFICE FOR ALL? – A POINT TO PONDER | Dr. Balaji Ramraj |
OP-05-06 | TRENDS IN MULTIDRUG-RESISTANT TUBERCULOSIS IN TAIWAN: INSIGHTS FROM REPORTED DATA, 2008-2022 | Ms. Mei-Mei Kuan |
OP-05-07 | EXPLORING AMPLIFICATION OF DRUG-RESISTANCE TB IN TAIWAN USING WHOLE GENOME SEQUENCING DATA | Ms. Chieh-Yin (Jenny) Wu |